Open Access
Issue
Vet. Res.
Volume 38, Number 2, March-April 2007
Respiratory viruses of domestic animals
Page(s) 153 - 180
DOI http://dx.doi.org/10.1051/vetres:2006053
Published online 25 January 2007
How to cite this article Vet. Res. (2007) 153-180
References of  Vet. Res. 38 (2007) 153-180
  1. Ahmadian G., Chambers P., Easton A.J., Detection and characterization of proteins encoded by the second ORF of the M2 gene of pneumoviruses, J. Gen. Virol. (1999) 80:2011-2016 [PubMed].
  2. Alansari H., Potgieter L.N., Molecular cloning and sequence analysis of the phosphoprotein, nucleocapsid protein, matrix protein and 22K (M2) protein of the ovine respiratory syncytial virus, J. Gen. Virol. (1994) 75:3597-3601 [PubMed].
  3. Ames T.R., The epidemiology of BRSV infection, Vet. Med. (1993) 88:881-885.
  4. Anderson K., King A.M., Lerch R.A., Wertz G.W., Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses, Virology (1992) 191:417-430 [CrossRef] [PubMed].
  5. Antonis A.F., Schrijver R.S., Daus F., Steverink P.J., Stockhofe N., Hensen E.J., Langedijk J.P., van der Most R.G., Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis, J. Virol. (2003) 77:12067-12073 [CrossRef] [PubMed].
  6. Arslanagic E., Matsumoto M., Suzuki K., Nerome K., Tsutsumi H., Hung T., Maturation of respiratory syncytial virus within HEp-2 cell cytoplasm, Acta Virol. (1996) 40:209-214 [PubMed].
  7. Atreya P.L., Peeples M.E., Collins P.L., The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication, J. Virol. (1998) 72:1452-1461 [PubMed].
  8. Atreya P.L., Kulkarni S., Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA, Virology (1999) 261:227-241 [CrossRef] [PubMed].
  9. Baker J.C., Ames T.R., Markham R.J., Seroepizootiologic study of bovine respiratory syncytial virus in a dairy herd, Am. J. Vet. Res. (1986) 47:240-245.
  10. Belanger F., Berthiaume L., Alain R., Lussier G., Trudel M., Electron microscopic evidence for bridges between bovine respiratory syncytial virus particles, J. Gen. Virol. (1988) 69:1421-1424 [PubMed].
  11. Belknap E., Baker J.C., Patterson J.S., Walker R.D., Haines D.M., Clark E.G., The role of passive immunity in bovine respiratory syncytial virus-infected calves, J. Infect. Dis. (1991) 163:470-476 [PubMed].
  12. Belknap E.B., Recognizing the clinical signs of BRSV infection, Vet. Med. (1993) 88:883-887.
  13. Belshe R.B., Van Voris L.P., Mufson M.A., Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial, J. Infect. Dis. (1982) 145:311-319 [PubMed].
  14. Bermingham A., Collins P.L., The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription, Proc. Natl. Acad. Sci. USA (1999) 96:11259-11264 [CrossRef] [PubMed].
  15. Bitko V., Velazquez A., Yang L., Yang Y.C., Barik S., Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-$\kappa$B and is inhibited by sodium salicylate and aspirin, Virology (1997) 232:369-378 [CrossRef] [PubMed].
  16. Bossert B., Conzelmann K.-K., Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells, J. Virol. (2002) 76:4287-4293 [CrossRef] [PubMed].
  17. Bossert B., Marozin S., Conzelmann K.K., Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3, J. Virol. (2003) 77:8661-8668 [CrossRef] [PubMed].
  18. Brown G., Aitken J., Rixon H.W.M., Sugrue R.J., Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells, J. Gen. Virol. (2002) 83:611-621 [PubMed].
  19. Bryson D.E., Necroscopy findings associated with BRSV pneumonia, Vet. Med. (1993) 88:894-899.
  20. Buchholz U.J., Finke S., Conzelmann K.-K., Generation of bovine respiratory syncytial virus (BRSV) from cDNA:BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter, J. Virol. (1999) 73:251-259 [PubMed].
  21. Buchholz U.J., Granzow H., Schuldt K., Whitehead S.S., Murphy B.R., Collins P.L., Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host range and evaluation as a live-attenuated HRSV vaccine, J. Virol. (2000) 74:1187-1199 [CrossRef] [PubMed].
  22. Bukreyev A., Whitehead S.S., Murphy B.R., Collins P.L., Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of mice, J. Virol. (1997) 71:8973-8982 [PubMed].
  23. Bukreyev A., Whitehead S.S., Bukreyeva N., Murphy B.R., Collins P.L., Interferon $\gamma $ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity, Proc. Natl. Acad. Sci. USA (1999) 96:2367-2372 [CrossRef] [PubMed].
  24. Bukreyev A., Whitehead S.S., Prussin C., Murphy B.R., Collins P.L., Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines, J. Virol. (2000) 74:7151-7157 [CrossRef] [PubMed].
  25. Bukreyev A., Belyakov I.M., Berzofsky J.A., Murphy P.M., Collins P.L., Granulocyte colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells, J. Virol. (2001) 75:12128-12140 [CrossRef] [PubMed].
  26. Bunt A.A., Milne R.G., Sayaya T., Verbeek M., Vetten H.J., Walsh J.A., Paramyxoviridae, in: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A. (Eds.), Virus taxonomy, Eigth report of the International Committee on Taxonomy of Viruses, Elsevier, Academic Press, London, 2005, pp. 655-671.
  27. Caldow G.L., Edwards S., Nixon P., Peters A.R., Associations between viral infection and respiratory disease in young beef bulls, Vet. Rec. (1988) 122:529-531 [PubMed].
  28. Chang J., Braciale T.J., Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract, Nat. Med. (2002) 8:54-60 [CrossRef] [PubMed].
  29. Citterio C.V., Luzzago C., Sala M., Sironi G., Gatti P., Gaffuri A., Lanfranchi P., Serological study of a population of alpine chamois (Rupicapra r rupicapra) affected by an outbreak of respiratory disease, Vet. Rec. (2003) 153:592-596 [PubMed].
  30. Collins P.L., Hill M.G., Johnson P.R., The two open reading frames of the 22K mRNA of human respiratory syncytial virus: sequence comparison of antigenic subgroups A and B and expression in vitro, J. Gen. Virol. (1990) 71:3015-3020 [PubMed].
  31. Collins P.L., Mottet G., Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A, J. Gen. Virol. (1992) 73:849-863 [PubMed].
  32. Collins P.L., Hill M.G., Camargo E., Grosfeld H., Chanock R.M., Murphy B.R., Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development, Proc. Natl. Acad. Sci. USA (1995) 92:11563-11567 [CrossRef] [PubMed].
  33. Collins P.L., Chanock R.M., Murphy B.R., Respiratory syncytial virus, in: Kripe D.M., Howley P.M. (Eds.), Fields virology, 4th ed., Lippincott Williams and Wilkins, Philadelphia, 2001, pp. 1443-1485.
  34. Collins P.L., Murphy B.R., New generation live vaccines against human respiratory syncytial virus designed by reverse genetics, Proc. Am. Thorac. Soc. (2005) 2:166-173 [CrossRef] [PubMed].
  35. Connors M., Kulkarni A.B., Firestone C.-Y., Holmes K.L., Morse H.C. III, Sotnkov A.V., Murphy B.R., Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunised BALB/c mice is abrogated by depletion of CD4+ T-cells, J. Virol. (1992) 66:7444-7451 [PubMed].
  36. Connors M., Giese N.A., Kulkarni A.B., Firestone C.Y., Morse H.C., Murphy B.R., Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10, J. Virol. (1994) 68:5321-5325 [PubMed].
  37. Conzelmann K.K., Reverse genetics of mononegavirales, Curr. Top. Microbiol. Immunol. (2004) 283:1-41 [PubMed].
  38. Crowe J.E. Jr., Bui P.T., Siber G.R., Elkins W.R., Chanock R.M., Murphy B.R., Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization, Vaccine (1995) 13:847-855 [CrossRef] [PubMed].
  39. De Jong M.C.M., Van der Poel W.H.M., Kramps J.A., Brand A., Van Oirschot J.T., Quantitative investigation of population persistence and recurrent outbreaks of bovine respiratory syncytial virus on dairy farms, Am. J. Vet. Res. (1996) 57:628-633 [PubMed].
  40. Dunbar M.R., Jessup D.A., Evermann J.F., Foreyt W.J., Seroprevalence of respiratory syncytial virus in free-ranging bighorn sheep, J. Am. Vet. Med. Assoc. (1985) 187:1173-1174 [PubMed].
  41. Elvander M., Severe respiratory disease in dairy cows caused by infection with bovine respiratory syncytial virus, Vet. Rec. (1996) 138:101-105.
  42. Evans J.E., Cane P.A., Pringle C.R., Expression and characterisation of NS1 and NS2 proteins of respiratory syncytial virus, Virus Res. (1996) 43:155-161 [CrossRef] [PubMed].
  43. Feldman S.A., Crim R.L., Audet S.A., Beeler J.A., Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex, Arch. Virol. (2001) 146:2369-2383 [CrossRef] [PubMed].
  44. Furze J., Wertz G., Lerch R., Taylor G., Antigenic heterogenicity of the attachment protein of bovine respiratory syncytial virus, J. Gen. Virol. (1994) 75:363-370 [PubMed].
  45. Furze J.M., Roberts S.R., Wertz G.W., Taylor G., Antigenically distinct G glycoproteins of BRSV strains share a high degree of genetic homogeneity, Virology (1997) 231:48-58 [CrossRef] [PubMed].
  46. Gaddum R.M., Cook R.S., Furze J.M., Ellis S.A., Taylor G., Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes, Immunology (2003) 108:220-229 [PubMed].
  47. Gershwin L.J., Schelegle E.S., Gunther R.A., Anderson M.L., Woolums A.R., Larochelle D.R., Boyle G.A., Friebertshauser K.E., Singer R.S., A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology, Vaccine (1998) 16:1225-1236 [CrossRef] [PubMed].
  48. Ghildyal R., Hartley C., Varrasso A., Meanger J., Voelker D.R., Anders E.M., Mills J., Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity, J. Infect. Dis. (1999) 180:2009-2013 [CrossRef] [PubMed].
  49. Gonzalez-Reyes L., Ruiz-Arguello M.B., Garcia-Barreno B., Calder L., Lopez J.A., Albar J.P., Skehel J.J., Wiley D.C., Melero J.A., Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion, Proc. Natl. Acad. Sci. USA (2001) 98:9859-9864 [CrossRef] [PubMed].
  50. Goodbourn S., Didcock L., Randall R.E., Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures, J. Gen. Virol. (2000) 81:2341-2364 [PubMed].
  51. Graham B.S., Henderson G.S., Tang Y.W., Lu X., Neuzil K.M., Colley D.G., Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus, J. Immunol. (1993) 151:2032-2040 [PubMed].
  52. Haeberle H.A., Takizawa R., Casola A., Brasier A.R., Dieterich H.J., Van Rooijen N., Gatalica Z., Garofalo R.P., Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways, J. Infect. Dis. (2002) 186:1199-1206 [CrossRef] [PubMed].
  53. Haeberle H.A., Casola A., Gatalica Z., Petronella S., Dieterich H.J., Ernst P.B., Brasier A.R., Garofalo R.P., I$\kappa$B kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection, J. Virol. (2004) 78:2232-2241 [CrossRef] [PubMed].
  54. Hagglund S., Svensson C., Emanuelson U., Valarcher J.F., Alenius S., Dynamics of virus infections involved in the bovine respiratory disease complex in Swedish dairy herds, Vet. J. (2006) 172:320-328 [CrossRef] [PubMed].
  55. Hall C.B., Douglas R.G. Jr., Geiman J.M., Possible transmission by fomites of respiratory syncytial virus, J. Infect. Dis. (1980) 141:98-102 [PubMed].
  56. Harcourt J., Alvarez R., Jones L.P., Henderson C., Anderson L.J., Tripp R.A., Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses, J. Immunol. (2006) 176:1600-1608 [PubMed].
  57. Hardy R.W., Wertz G.W., The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription, J. Virol. (1998) 72:520-526 [PubMed].
  58. Harrison A.M., Bonville C.A., Rosenberg H.F., Domachowske J.B., Respiratory syncytial virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation, Am. J. Respir. Crit. Care Med. (1999) 159:1918-1924 [PubMed].
  59. Heminway B.R., Yu Y., Tanaka Y., Perrine K.G., Gustafson E., Bernstein J.M., Galinski M.S., Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion, Virology (1994) 200:801-805 [CrossRef] [PubMed].
  60. Hendricks D.A., Baradaran K., McIntosh K., Patterson J.L., Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells, J. Gen. Virol. (1987) 68:1705-1714 [PubMed].
  61. Hendricks D.A., McIntosh K., Patterson J.L., Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus, J. Virol. (1988) 62:2228-2233 [PubMed].
  62. Hickling T.P., Bright H., Wing K., Gower D., Martin S.L., Sim R.B., Malhotra R., A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo, Eur. J. Immunol. (1999) 29:3478-3484 [PubMed].
  63. Inaba Y., Tanaka Y., Sato K., Omori T., Matumoto M., Bovine respiratory syncytial virus - Studies on an outbreak in Japan, 1968-1969, Jpn. J. Microbiol. (1972) 16:373-383 [PubMed].
  64. Kapikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., Stewart C.E., An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine, Am. J. Epidemiol. (1969) 89:405-421 [PubMed].
  65. Karger A., Schmidt U., Buchholz U.J., Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin, J. Gen. Virol. (2001) 82:631-640 [PubMed].
  66. Keles I., Woldehiwet Z., Murray R.D., In vitro studies on mechanisms of immunosuppression associated with bovine respiratory syncytial virus, J. Comp. Pathol. (1998) 118:337-345 [PubMed].
  67. Kim H.W., Canchola J.G., Brandt C.D., Pyles G., Chanock R.M., Jensen K., Parrott R.H., Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine, Am. J. Epidemiol. (1969) 89:422-434 [PubMed].
  68. Kimman T.G., Westenbrink F., Straver P.J., Van Zaane D., Schreuder B.E., Isotype-specific ELISAs for the detection of antibodies to bovine respiratory syncytial virus, Res. Vet. Sci. (1987) 43:180-187 [PubMed].
  69. Kimman T.G., Westenbrink F., Schreuder B.E., Straver P.J., Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies, J. Clin. Microbiol. (1987) 25:1097-1106 [PubMed].
  70. Kimman T.G., Zimmer G.M., Westenbrink F., Mars J., van Leeuwen E., Epidemiological study of bovine respiratory syncytial virus infections in calves: influence of maternal antibodies on the outcome of disease, Vet. Rec. (1988) 123:104-109 [PubMed].
  71. Kimman T.G., Straver P.J., Zimmer G.M., Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: morphologic and serologic findings, Am. J. Vet. Res. (1989) 50:684-693 [PubMed].
  72. Konig P., Giesow K., Schuldt K., Buchholz U.J., Keil G.M., A novel protein expression strategy using recombinant bovine respiratory syncytial virus (BRSV): modifications of the peptide sequence between the two furin cleavage sites of the BRSV fusion protein yield secreted proteins, but affect processing and function of the BRSV fusion protein, J. Gen. Virol. (2004) 85:1815-1824 [CrossRef] [PubMed].
  73. Kuo L., Grosfeld H., Cristina J., Hill M.G., Collins P.L., Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus, J. Virol. (1996) 70:6892-6901 [PubMed].
  74. Kuo L., Fearns R., Collins P.L., Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA, J. Virol. (1997) 71:4944-4953 [PubMed].
  75. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W., Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus, Nat. Immunol. (2000) 1:398-401 [CrossRef] [PubMed].
  76. Lahti M., Lofgren J., Marttila R., Renko M., Klaavuniemi T., Haataja R., Ramet M., Hallman M., Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection, Pediatr. Res. (2002) 51:696-699 [PubMed].
  77. Lambert D.M., Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins, Virology (1988) 164:458-466.
  78. Langedijk J.P.M., Schaaper W.M.M., Meloen R.H., van Oirschot J.T., Proposed three-dimensional model for the attachment protein G or respiratory syncytial virus, J. Gen. Virol. (1996) 77:1249-1257 [PubMed].
  79. Langedijk J.P., Meloen R.H., Taylor G., Furze J.M., van Oirschot J.T., Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus, J. Virol. (1997) 71:4055-4061 [PubMed].
  80. Langedijk J.P., de Groot B.L., Berendsen H.J., van Oirschot J.T., Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor, Virology (1998) 243:293-302 [CrossRef] [PubMed].
  81. Larsen L.E., Uttenthal A., Arctander P., Tjornehoj K., Viuff B., Rontved C., Ronshold L., Alexandersen S., Blixenkrone-Moller M., Serological and genetic characterisation of bovine respiratory syncytial virus (BRSV) indicates that Danish isolates belong to the intermediate subgroup: no evidence of a selective effect on the variability of G protein nucleotide sequence by prior cell culture adaption and passages in cell culture or calves, Vet. Microbiol. (1998) 62:265-279 [CrossRef] [PubMed].
  82. Lehmkuhl H.D., Smith M.H., Cutlip R.C., Morphogenesis and ultrastructure of caprine respiratory syncytial virus, Arch. Virol. (1980) 65:269-276 [CrossRef] [PubMed].
  83. Lerch R.A., Anderson K., Wertz G.W., Nucleotide sequence analysis and expression from recombinant vectors demonstrate that the attachment protein G of bovine respiratory syncytial virus is distinct from that of human respiratory syncytial virus, J. Virol. (1990) 64:5559-5569 [PubMed].
  84. Lerch R.A., Anderson K., Amann V.L., Wertz G.W., Nucleotide sequence analysis of the bovine respiratory syncytial virus fusion protein mRNA and expression from a recombinant vaccinia virus, Virology (1991) 181:118-131 [CrossRef] [PubMed].
  85. LeVine A.M., Gwozdz J., Stark J., Bruno M., Whitsett J., Korfhagen T., Surfactant protein-A enhances respiratory syncytial virus clearance in vivo, J. Clin. Invest. (1999) 103:1015-1021 [PubMed].
  86. Levine S., Klaiber Franco R., Paradiso P.R., Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus, J. Gen. Virol. (1987) 68:2521-2524 [PubMed].
  87. Lo M.S., Brazas R.M., Holtzman M.J., Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness, J. Virol. (2005) 79:9315-9319 [CrossRef] [PubMed].
  88. Lofgren J., Ramet M., Renko M., Marttila R., Hallman M., Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants, J. Infect. Dis. (2002) 185:283-289 [CrossRef] [PubMed].
  89. Maher C.F., Hussell T., Blair E., Ring C.J., Openshaw P.J., Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity, Microbes Infect. (2004) 6:1049-1055 [CrossRef] [PubMed].
  90. Malhotra R., Ward M., Bright H., Priest R., Foster M.R., Hurle M., Blair E., Bird M., Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells, Microbes Infect. (2003) 5:123-133 [CrossRef] [PubMed].
  91. Mallipeddi S.K., Samal S.K., Sequence comparison between the phosphoprotein mRNAs of human and bovine respiratory syncytial viruses identifies a divergent domain in the predicted protein, J. Gen. Virol. (1992) 73:2441-2444 [PubMed].
  92. Mallipeddi S.K., Samal S.K., Sequence variability of the glycoprotein gene of bovine respiratory syncytial virus, J. Gen. Virol. 74 (1993) 2001-2004 [PubMed].
  93. Mallipeddi S.K., Lupiani B., Samal S.K., Mapping the domains on the phosphoprotein of bovine respiratory syncytial virus required for N-P interaction using a two-hybrid system, J. Gen. Virol. (1996) 77:1019-1023 [PubMed].
  94. Mars M.H., Bruschke C.J., van Oirschot J.T., Airborne transmission of BHV1, BRSV, and BVDV among cattle is possible under experimental conditions, Vet. Microbiol. (1999) 66:197-207 [CrossRef] [PubMed].
  95. Miller A.L., Bowlin T.L., Lukacs N.W., Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo, J. Infect. Dis. (2004) 189:1419-1430 [CrossRef] [PubMed].
  96. Monick M.M., Yarovinsky T.O., Powers L.S., Butler N.S., Carter A.B., Gudmundsson G., Hunninghake G.W., Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin, J. Biol. Chem. (2003) 278:53035-53044 [CrossRef] [PubMed].
  97. Murphy B.R., Prince G.A., Walsh E.E., Kim H.W., Parrott R.H., Hemming V.G., Rodriguez W.J., Chanock R.M., Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine, J. Clin. Microbiol. (1986) 24:197-202 [PubMed].
  98. Nettleton P.F., Gilray J.A., Caldow G., Gidlow J.R., Durkovic B., Vilcek S., Recent isolates of bovine respiratory syncytial virus from Britain are more closely related to isolates from USA than to earlier British and current mainland European isolates, J. Vet. Med. B Infect. Dis. Vet. Public Health (2003) 50:196-199 [PubMed].
  99. Noah T., Becker S., Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus, Clin. Immunol. (2000) 97:43-49 [CrossRef] [PubMed].
  100. Paccaud M.F., Jacquier C.L., A respiratory syncytial virus of bovine origin, Arch. Gesamte Virusforsch. (1970) 30:327-342 [CrossRef] [PubMed].
  101. Pastey M.K., Samal S.K., Structure and sequence comparison of bovine respiratory syncytial virus fusion protein, Virus Res. (1993) 29:195-202 [CrossRef] [PubMed].
  102. Pastey M.K., Samal S.K., Nucleotide sequence analysis of the non-structural NS1 (1C) and NS2 (1B) protein genes of bovine respiratory syncytial virus, J. Gen. Virol. (1995) 76:193-197 [PubMed].
  103. Polack F.P., Teng M.N., Collins P.L., Prince G.A., Exner M., Regele H., Lirman D.D., Rabold R., Hoffman S.J., Karp C.L., Kleeberger S.R., Wills-Karp M., Karron R.A., A role for immune complexes in enhanced respiratory syncytial virus disease, J. Exp. Med. (2002) 196:859-865 [CrossRef] [PubMed].
  104. Polack F.P., Irusta P.M., Hoffman S.J., Schiatti M.P., Melendi G.A., Delgado M.F., Laham F.R., Thumar B., Hendry R.M., Melero J.A., Karron R.A., Collins P.L., Kleeberger S.R., The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin, Proc. Natl. Acad. Sci. USA (2005) 102:8996-9001 [CrossRef] [PubMed].
  105. Prozzi D., Walravens K., Langedijk J.P., Daus F., Kramps J.A., Letesson J.J., Antigenic and molecular analyses of the variability of bovine respiratory syncytial virus G glycoprotein, J. Gen. Virol. (1997) 78:359-366 [PubMed].
  106. Ramaswamy M., Shi L., Varga S.M., Barik S., Behlke M.A., Look D.C., Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction, Virology (2006) 344:328-339 [CrossRef] [PubMed].
  107. Rivera H., Madewell B.R., Ameghino E., Serologic survey of viral antibodies in the Peruvian alpaca (Lama pacos), Am. J. Vet. Res. (1987) 48:189-191 [PubMed].
  108. Roberts S.R., Lichtenstein D., Ball L.A., Wertz G.W., The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons, J. Virol. (1994) 68:4538-4546 [PubMed].
  109. Rontved C.M., Tjornehoj K., Viuff B., Larsen L.E., Godson D.L., Ronsholt L., Alexandersen S., Increased pulmonary secretion of tumor necrosis factor-alpha in calves experimentally infected with bovine respiratory syncytial virus, Vet. Immunol. Immunopathol. (2000) 76:199-214 [PubMed].
  110. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W., Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression, J. Virol. (2005) 79:3350-3357 [CrossRef] [PubMed].
  111. Samal S.K., Zamora M., Nucleotide sequence analysis of a matrix and small hydrophobic protein dicistronic mRNA of bovine respiratory syncytial virus demonstrates extensive sequence divergence of the small hydrophobic protein from that of human respiratory syncytial virus, J. Gen. Virol. (1991) 72:1715-1720 [PubMed].
  112. Samal S.K., Zamora M., McPhillips T.H., Mohanty S.B., Molecular cloning and sequence analysis of bovine respiratory syncytial virus mRNA encoding the major nucleocapsid protein, Virology (1991) 180:453-456.
  113. Sausker E.A., Dyer N.W., Seroprevalence of OHV-2, BVDV, BHV-1, and BRSV in ranch-raised bison (Bison bison), J. Vet. Diagn. Invest. (2002) 14:68-70 [PubMed].
  114. Schelcher F., Salat O., Bezille P., Espinasse J., Approche seroépidémiologique des troubles respiratoires épizootiques des veaux d'Aveyron : rôle du virus respiratoire syncytial, Rev. Med. Vet. (1990) 141:117-123.
  115. Schlender J., Bossert B., Buchholz U., Conzelmann K.-K., Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response, J. Virol. (2000) 74:8234-8242 [CrossRef] [PubMed].
  116. Schlender J., Walliser G., Fricke J., Conzelmann K.-K., Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact, J. Virol. (2002) 76:1163-1170 [PubMed].
  117. Schlender J., Zimmer G., Herrler G., Conzelmann K.-K., Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection, J. Virol. (2003) 77:4609-4616 [CrossRef] [PubMed].
  118. Schmidt U., Breyer J., Polster U., Gershwin L.J., Buchholz U., Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV, J. Virol. (2002) 76:12355-12359 [CrossRef] [PubMed].
  119. Schreiber P., Matheise J.P., Dessy F., Heimann M., Letesson J.J., Coppe P., Collard A., High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated vaccine, J. Vet. Med. B Infect. Dis. Vet. Public Health (2000) 47:535-550 [PubMed].
  120. Schrijver R.S., Daus F., Kramps J.A., Langedijk J.P., Buijs R., Middel W.G., Taylor G., Furze J., Huyben M.W., van Oirschot J.T., Subgrouping of bovine respiratory syncytial virus strains detected in lung tissue, Vet. Microbiol. (1996) 53:253-260 [CrossRef] [PubMed].
  121. Sharma R., Woldehiwet Z., Depression of lymphocyte responses to phytohaemagglutinin in lambs experimentally infected with bovine respiratory syncytial virus, Res. Vet. Sci. (1991) 50:152-156 [PubMed].
  122. Smith M.H., Frey M.L., Dierks R.E., Isolation and characterisation of a bovine syncytial virus, Vet. Rec. (1974) 94:599.
  123. Smith M.H., Lehmkhul H.D., Phillips S.M.I., Isolation and characterization of respiratory syncytial virus from goats, Am. Assoc. Vet. Lab. Diagn. (1979) 22:259-269.
  124. Spann K.M., Tran K.C., Chi B., Rabin R.L., Collins P.L., Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages, J. Virol. (2004) 78:4363-4369 [CrossRef] [PubMed].
  125. Spann K.M., Tran K.C., Collins P.L., Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-$\kappa$B, and proinflammatory cytokines, J. Virol. (2005) 79:5353-5362 [CrossRef] [PubMed].
  126. Spilki F.R., Almeida R.S., Domingues H.G., D'Arce R.C., Ferreira H.L., Campalans J., Costa S.C., Arns C.W., Phylogenetic relationships of Brazilian bovine respiratory syncytial virus isolates and molecular homology modeling of attachment glycoprotein, Virus Res. (2006) 116:30-37 [CrossRef] [PubMed].
  127. Stott E.J., Thomas L.H., Collins A.P., Crouch S., Jebbett J., Smith G.S., Luther P.D., Caswell R., A survey of virus infections of the respiratory tract of cattle and their association with disease, J. Hyg. (Lond.) (1980) 85:257-270 [PubMed].
  128. Stott E.J., Taylor G., Respiratory syncytial virus. Brief review, Arch. Virol. (1985) 84:1-52 [CrossRef] [PubMed].
  129. Tang R.S., Nguyen N., Zhou H., Jin H., Clustered charge-to-alanine mutagenesis of human respiratory syncytial virus L polymerase generates temperature-sensitive viruses, Virology (2002) 302:207-216 [CrossRef] [PubMed].
  130. Taylor G., Stott E.J., Furze J., Ford J., Sopp P., Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies, J. Gen. Virol. (1992) 73:2217-2223 [PubMed].
  131. Taylor G., Thomas L.H., Wyld S.G., Furze J., Sopp P., Howard C.J., Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves, J. Virol. (1995) 69:6658-6664 [PubMed].
  132. Taylor G., Thomas L.H., Furze J.M., Cook R.S., Wyld S.G., Lerch R., Hardy R., Wertz G.W., Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions, J. Gen. Virol. (1997) 78:3195-3206 [PubMed].
  133. Taylor G., Rijsewijk F.A.M., Thomas L.H., Wyld S.G., Gaddum R.M., Cook R.S., Morrison W.I., Hensen E., van Oirschot J.T., Keil G., Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV, J. Gen. Virol. (1998) 79:1759-1767 [PubMed].
  134. Taylor G., Bruce C., Barbet A.F., Wyld S.G., Thomas L.H., DNA vaccination against respiratory syncytial virus in young calves, Vaccine (2005) 23:1242-1250 [CrossRef] [PubMed].
  135. Techaarpornkul S., Baretto N., Peeples M.E., Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene, J. Virol. (2001) 75:6825-6834.
  136. Teng M.N., Collins P.L., Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles, J. Virol. (1998) 72:5707-5716 [PubMed].
  137. Teng M.N., Collins P.L., Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein, J. Virol. (1999) 73:466-473 [PubMed].
  138. Teng M.N., Whitehead S.S., Collins P.L., Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo, Virology (2001) 289:283-296 [CrossRef] [PubMed].
  139. Teng M.N., Collins P.L., The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo, J. Virol. (2002) 76:6164-6171 [CrossRef] [PubMed].
  140. Thomas L.H., Stott E.J., Jones P.W., Jebbett N.J., Collins A.P., The possible role of respiratory syncytial virus and Pasteurella spp. in calf respiratory disease, Vet. Rec. (1980) 107:304-307 [PubMed].
  141. Thomas L.H., Stott E.J., Collins A.P., Jebbett J., Experimental pneumonia in gnotobiotic calves produced by respiratory syncytial virus, Br. J. Exp. Pathol. (1984) 65:19-28 [PubMed].
  142. Thomas L.H., Stott E.J., Collins A.P., Crouch S., Jebbett J., Infection of gnotobiotic calves with a bovine and human isolate of respiratory syncytial virus. Modification of the response by dexamethasone, Arch. Virol. (1984) 79:67-77 [CrossRef] [PubMed].
  143. Thomas L.H., Cook R.S., Howard C.J., Gaddum R.M., Taylor G., Influence of selective T-lymphocyte depletion on the lung pathology of gnotobiotic calves and the distribution of different T-lymphocyte subsets following challenge with bovine respiratory syncytial virus, Res. Vet. Sci. (1996) 61:38-44 [CrossRef] [PubMed].
  144. Thomas L.H., Cook R.S., Wyld S.G., Furze J.M., Taylor G., Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus, J. Infect. Dis. (1998) 177:874-880 [PubMed].
  145. Tjornehoj K., Uttenthal A., Viuff B., Larsen L.E., Rontved C., Ronsholt L., An experimental infection model for reproduction of calf pneumonia with bovine respiratory syncytial virus (BRSV) based on one combined exposure of calves, Res. Vet. Sci. (2003) 74:55-65 [CrossRef] [PubMed].
  146. Tripp R.A., Jones L.P., Haynes L.M., Zheng H.Q., Murphy P.M., Anderson L.J., CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein, Nat. Immunol. (2001) 2:732-738 [CrossRef] [PubMed].
  147. Trudel M., Nadon F., Simard C., Belanger F., Alain R., Seguin C., Lussier G., Comparison of caprine, human and bovine strains of respiratory syncytial virus, Arch. Virol. (1989) 107:141-149 [CrossRef] [PubMed].
  148. Ulloa L., Serra R., Asenjo A., Villanueva N., Interactions between cellular actin and human respiratory syncytial virus (HRSV), Virus Res. (1998) 53:13-25 [CrossRef] [PubMed].
  149. Uttenthal A., Jensen N.P., Blom J.Y., Viral aetiology of enzootic pneumonia in Danish dairy herds: diagnostic tools and epidemiology, Vet. Rec. (1996) 139:114-117 [PubMed].
  150. Valarcher J.-F., Schelcher F., Bourhy H., Evolution of bovine respiratory syncytial virus, J. Virol. (2000) 74:10714-10728 [CrossRef] [PubMed].
  151. Valarcher J.F., Bourhy H., Lavenu A., Bourges-Abella N., Roth M., Andreoletti O., Ave P., Schelcher F., Persistent infection of B lymphocytes by bovine respiratory syncytial virus, Virology (2001) 291:55-67 [CrossRef] [PubMed].
  152. Valarcher J.-F., Furze J., Wyld S., Cook R., Conzelmann K.-K., Taylor G., Role of type I interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses (BRSV) lacking NS proteins, J. Virol. (2003) 77:8426-8439 [CrossRef] [PubMed].
  153. Valarcher J.F., Furze J.M., Wyld S.G., Cook R., Zinkernagel R.M., Herrler G., Taylor G., Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves, J. Gen. Virol. (2006) 87:1659-1667 [CrossRef] [PubMed].
  154. Valentova V., Antonis A.F., Kovarcik K., Restriction enzyme analysis of RT-PCR amplicons as a rapid method for detection of genetic diversity among bovine respiratory syncytial virus isolates, Vet. Microbiol. (2005) 108:1-12 [CrossRef] [PubMed].
  155. Van der Poel W.H.M., Kramps J.A., Middel W.G.J., Van Oirschot J.T., Brand A., Diagnosis of bovine respiratory syncytial virus infections: a longitudinal epidemiological study in dairy herds, Arch. Virol. (1993) 133:309-321 [CrossRef] [PubMed].
  156. Van der Poel W.H.M., Brand A., Kramps A., van Oirschot J.T., Respiratory syncytial virus infections in human beings and in cattle, J. Infect. Dis. (1994) 29:215-228.
  157. Van der Poel W.H.M., Langedijk J.P.M., Kramps J.A., Middel W.G.J., Brand A., Van Oirschot J.T., Bovine respiratory syncytial virus antibodies in non-bovine species, Arch. Virol. (1995) 140:1549-1555 [CrossRef] [PubMed].
  158. Van der Poel W.H.M., Langedijk J.P.M., Kramps J.A., Middel W.G.J., Brand A., Van Oirschot J.T., Serological indication for persistence of bovine respiratory syncytial virus in cattle and attempts to detect the virus, Arch. Virol. (1997) 142:1682-1696.
  159. Verhoeff J., Van der Ban M., van Nieuwstadt A.P., Bovine respiratory syncytial virus infections in young dairy cattle: clinical and haematological findings, Vet. Rec. (1984) 114:9-12 [PubMed].
  160. Verhoeff J., van Nieuwstadt A.P., BRS virus, PI3 virus and BHV1 infections of young stock on self-contained dairy farms: epidemiological and clinical findings, Vet. Rec. (1984) 114:288-293 [PubMed].
  161. Viuff B., Uttenthal A., Tegtmeier C., Alexandersen S., Sites of replication of bovine respiratory syncytial virus in naturally infected calves as determined by in situ hybridisation, Vet. Pathol. (1996) 33:383-390 [PubMed].
  162. Viuff B., Tjornehoj K., Larsen L.E., Rontved C.M., Uttenthal A., Ronsholt L., Alexandersen S., Replication and clearance of respiratory syncytial virus. Apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus, Am. J. Pathol. (2002) 161:2195-2207 [PubMed].
  163. Waris M.E., Tsou C., Erdman D.D., Zaki S.R., Anderson L.J., Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern, J. Virol. (1996) 70:2852-2860 [PubMed].
  164. Weber E., Humbert B., Streckert H.-J., Werchau H., Nonstructural protein 2 (NS2) of respiratory syncytial virus (RSV) detected by an antipeptide serum, Respiration (1995) 62:27-33 [PubMed].
  165. Wertz G.W., Collins P.L., Huang Y., Gruber C., Levine S., Ball L.A., Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of membrane protein, Proc. Natl. Acad. Sci. USA (1985) 82:4075-4079 [CrossRef] [PubMed].
  166. Wertz G.W., Krieger M., Ball L.A., Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation, J. Virol. (1989) 63:4767-4776 [PubMed].
  167. Whitehead S.S., Bukreyev A., Teng M.N., Firestone C.-Y., St. Claire M., Elkins W.R., Collins P.L., Murphy B.R., Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees, J. Virol. (1999) 73:3438-3442 [PubMed].
  168. Woldehiwet Z., Sharma R., Evidence of immunosuppression by bovine respiratory syncytial virus, Scand. J. Immunol. (1992) Suppl. 11:75-80.
  169. Wright P.F., Belshe R.B., Kim H.W., Van Voris L.P., Chanock R.M., Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children, Infect. Immun. (1982) 37:397-400 [PubMed].
  170. Yaegashi G., Seimiya Y.M., Seki Y., Tsunemitsu H., Genetic and antigenic analyses of bovine respiratory syncytial virus detected in Japan, J. Vet. Med. Sci. (2005) 67:145-150 [CrossRef] [PubMed].
  171. Yunus A.S., Collins P.L., Samal S.K., Sequence analysis of a functional polymerase (L) gene of bovine respiratory syncytial virus: determination of minimal trans-acting requirements for RNA replication, J. Gen. Virol. (1998) 79:2231-2238 [PubMed].
  172. Zamora M., Samal S.K., Sequence analysis of M2 mRNA of bovine respiratory syncytial virus obtained from an F-M2 dicistronic mRNA suggests structural homology with that of human respiratory syncytial virus, J. Gen. Virol. (1992) 73:737-741 [PubMed].
  173. Zhang L., Peeples M.E., Boucher R.C., Collins P.L., Pickles R.J., Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology, J. Virol. (2002) 76:5654-5666 [CrossRef] [PubMed].
  174. Zimmer G., Budz L., Herrler G., Proteolytic activation of respiratory syncytial virus fusion protein, J. Biol. Chem. (2001) 276:31642-31650.
  175. Zimmer G., Conzelmann K.-K., Herrler G., Cleavage at the furin consensus sequence RAK/KR109 and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture, J. Virol. (2002) 76:9218-9224 [CrossRef] [PubMed].
  176. Zimmer G., Rohn M., McGregor G.P., Schemann M., Conzelmann K.K., Herrler G., Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus, J. Biol. Chem. (2003) 278:46854-46861 [CrossRef] [PubMed].